Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

[Personalized Therapy In Osteoporosis].

Schulz K, Kalscheuer H, Lehnert H.

Dtsch Med Wochenschr. 2019 Aug;144(16):1111-1119. doi: 10.1055/a-0841-8336. Epub 2019 Aug 15. German.

PMID:
31416102
2.

[New technologies in diabetes treatment].

Serfling G, Kalscheuer H, Schmid SM, Lehnert H.

Internist (Berl). 2019 Sep;60(9):912-916. doi: 10.1007/s00108-019-0654-z. Review. German.

PMID:
31375851
3.

Event Rates and Risk Factors for the Development of Diabetic Ketoacidosis in Adult Patients With Type 1 Diabetes: Analysis From the DPV Registry Based on 46,966 Patients.

Kalscheuer H, Seufert J, Lanzinger S, Rosenbauer J, Karges W, Bergis D, Mader JK, Zimny S, Schmid SM, Hummel M, Kerner W, Holl RW; DPV Initiative.

Diabetes Care. 2019 Mar;42(3):e34-e36. doi: 10.2337/dc18-1160. Epub 2019 Jan 17. No abstract available.

PMID:
30655381
4.

Metabolic Syndrome in Thyroid Disease.

Iwen KA, Oelkrug R, Kalscheuer H, Brabant G.

Front Horm Res. 2018;49:48-66. doi: 10.1159/000485996. Epub 2018 Apr 5. Review.

PMID:
29895010
5.

[Diabetic emergencies : Hypoglycemia, ketoacidotic and hyperglycemic hyperosmolar nonketotic coma].

Kalscheuer H, Serfling G, Schmid S, Lehnert H.

Internist (Berl). 2017 Oct;58(10):1020-1028. doi: 10.1007/s00108-017-0317-x. Review. German.

PMID:
28849301
6.

The Telomeric Complex and Metabolic Disease.

Kirchner H, Shaheen F, Kalscheuer H, Schmid SM, Oster H, Lehnert H.

Genes (Basel). 2017 Jul 7;8(7). pii: E176. doi: 10.3390/genes8070176. Review.

7.

[Diagnostic Approach to Manifestation of Type 1 Diabetes mellitus].

Kalscheuer H, Lehnert H.

Dtsch Med Wochenschr. 2017 May;142(10):723-730. doi: 10.1055/s-0042-114798. Epub 2017 May 17. German.

PMID:
28514820
8.

Diabetic Retinopathy Screening Ratio Is Improved When Using a Digital, Nonmydriatic Fundus Camera Onsite in a Diabetes Outpatient Clinic.

Roser P, Kalscheuer H, Groener JB, Lehnhoff D, Klein R, Auffarth GU, Nawroth PP, Schuett F, Rudofsky G.

J Diabetes Res. 2016;2016:4101890. doi: 10.1155/2016/4101890. Epub 2016 Jan 21.

9.

Plasma myostatin is only a weak predictor for weight maintenance in obese adults.

Tsioga MN, Oikonomou D, Vittas S, Kalscheuer H, Roeder E, Wintgens KF, Nawroth PP, Wolfrum C, Rudofsky G.

Exp Clin Endocrinol Diabetes. 2015 Sep;123(8):466-72. doi: 10.1055/s-0035-1559663. Epub 2015 Sep 22.

PMID:
26393401
10.

Xenograft tolerance and immune function of human T cells developing in pig thymus xenografts.

Kalscheuer H, Onoe T, Dahmani A, Li HW, Hölzl M, Yamada K, Sykes M.

J Immunol. 2014 Apr 1;192(7):3442-50. doi: 10.4049/jimmunol.1302886. Epub 2014 Mar 3.

11.

C332C genotype of glyoxalase 1 and its association with late diabetic complications.

Groener JB, Reismann P, Fleming T, Kalscheuer H, Lehnhoff D, Hamann A, Roser P, Bierhaus A, Nawroth PP, Rudofsky G.

Exp Clin Endocrinol Diabetes. 2013 Jul;121(7):436-9. doi: 10.1055/s-0033-1345124. Epub 2013 Jun 17.

PMID:
23775136
12.

A model for personalized in vivo analysis of human immune responsiveness.

Kalscheuer H, Danzl N, Onoe T, Faust T, Winchester R, Goland R, Greenberg E, Spitzer TR, Savage DG, Tahara H, Choi G, Yang YG, Sykes M.

Sci Transl Med. 2012 Mar 14;4(125):125ra30. doi: 10.1126/scitranslmed.3003481.

13.

Human natural regulatory T cell development, suppressive function, and postthymic maturation in a humanized mouse model.

Onoe T, Kalscheuer H, Danzl N, Chittenden M, Zhao G, Yang YG, Sykes M.

J Immunol. 2011 Oct 1;187(7):3895-903. doi: 10.4049/jimmunol.1100394. Epub 2011 Aug 29.

14.

Homeostatic expansion and phenotypic conversion of human T cells depend on peripheral interactions with APCs.

Onoe T, Kalscheuer H, Chittenden M, Zhao G, Yang YG, Sykes M.

J Immunol. 2010 Jun 15;184(12):6756-65. doi: 10.4049/jimmunol.0901711. Epub 2010 May 10.

15.

Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.

Pan Y, Luo B, Sozen H, Kalscheuer H, Blazar BR, Sutherland DE, Hering BJ, Guo Z.

Transplantation. 2003 Jul 15;76(1):216-24.

PMID:
12865813
16.

A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice.

Guo Z, Wu T, Sozen H, Pan Y, Heuss N, Kalscheuer H, Sutherland DE, Blazar BR, Hering BJ.

Transplantation. 2003 Apr 15;75(7):909-15.

PMID:
12698073
17.

Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.

Wu T, Sozen H, Luo B, Heuss N, Kalscheuer H, Lan P, Sutherland DE, Hering BJ, Guo Z.

Bone Marrow Transplant. 2002 Jun;29(12):949-56.

Supplemental Content

Loading ...
Support Center